−£6,055
vs Mar 2024Active09516072Private limited companyRhyl
CARDYCAN LIMITED
Significant control: Susan Mary Cardy (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Cardycan Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
CARDYCAN LIMITED is an active private limited company (company number 09516072) incorporated on 28 March 2015, registered in Rhyl. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 March 2025, showing net assets of −£6,055, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 1775% on the prior period (−£323).
Peer position · net assets
By net assets it sits in the bottom quarter of 278 comparable companies in Other (median £129, upper quartile £59k).
02
Ownership and control
- Dr Susan Mary Cardy
- owns 75–100% of shares
- holds 75–100% of voting rights
- Dr Donald Leonard Nicholas Cardy
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 28 March 201511 yrs ago
- Next accounts due
- 31 December 2026in 69 days
- Confirmation statement due
- 11 April 2027in 170 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
2
No changevs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | −£6,055 | — | — | — | — | — | 2 |
| 31 March 2024 | −£323 | — | — | — | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets below zeroNet assets £-6,055 at 31 March 2025
- Net assets down 25% or more on the prior period-1774.6% vs prior period
- Incorporated five or more years agoIncorporated 28 March 2015
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 170 days
- Next accounts duein 69 days
- Accounts period endNet liabilities £6,055 · micro accounts
- Accounts period endNet liabilities £323 · micro accounts
- Incorporated
08
Similar companies in the UK
- DAVID DAVIES PHARMA CONSULTANTS LTDYork · inc. Mar 2015
- MICRO BIO CONSULTANTS LIMITEDNorthwich · inc. Apr 2015
- SNIPR TECHNOLOGIES LIMITEDPeterborough · inc. May 2015
- AXONICS MODULATION TECHNOLOGIES, U.K. LIMITEDHemel Hempstead · inc. Jun 2015
- CADDISFLY RESEARCH AND DEVELOPMENT LTDNr Dereham · inc. Jun 2015
- BUSINESS TECHNIQUE LIMITEDHigh Wycombe · inc. Jan 2015
All companies incorporated on 28 March 2015 · in Mar 2015.
09
Reminders for CARDYCAN LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.